Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is regarded as a leading cause of cancer-related deaths, and its progression is associated with hypoxia and the induction of hypoxia-inducible factor (HIF). Meloxicam, a selective cyclooxygenase-2 (COX-2) inhibitor, induces cell death in various malignancies. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yinghong, Dong, Xiaofeng, Xiu, Peng, Wang, Xin, Yang, Jianrong, Li, Lei, Li, Zhongchao, Sun, Pengfei, Shi, Xuetao, Zhong, Jingtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128048/
https://www.ncbi.nlm.nih.gov/pubmed/32273947
http://dx.doi.org/10.1155/2020/7079308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128048/
https://www.ncbi.nlm.nih.gov/pubmed/32273947
http://dx.doi.org/10.1155/2020/7079308

Ejemplares similares